1 Min Read
Oct 26 (Reuters) - Novartis AG:
* NOVARTIS RECEIVES APPROVAL FOR COSENTYX® LABEL UPDATE IN EUROPE TO INCLUDE DOSING FLEXIBILITY IN PSORIATIC ARTHRITIS Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.